Objective: To determine the outcomes of modified radical vulvectomy for carcinoma vulva in terms of compliance with key quality standards set by southwest gynecological tumor panel.¹ Design: Cross-sectional study of prospectively collected data with cross-checking against the histopathology report. Setting: MCH Unit II, Pakistan Institute of Medical Sciences, Islamabad, Pakistan. Duration: Patients presenting with carcinoma vulva to MCH Unit II of 4 years’ duration from June 2013 to May 2017. Methods: The study includes prospectively maintained data of patients presenting with advanced carcinoma vulva and undergoing modified radical vulvectomy as a primary surgical procedure. Data analysis was done to determine the outcome of the procedure in terms of compliance with the key quality standards. Results: During the study period, 16 patients presented with vulval carcinoma. The majority of patients were at an advanced stage, with stage III 81% (n = 13) at presentation. Squamous cell carcinoma was the most common tissue variant. Modified radical vulvectomy with inguinofemoral lymphadenectomy was performed up to stage III disease, while patients with stage IV disease were referred to the oncology department. Regarding compliance with international quality standards, optimum inguinofemoral node dissection and surgical excision margin of >2 cm were achieved in 100% of cases, and histopathologically confirmed tumor-free margins were achieved in 94% of cases. Conclusion: Modified radical vulvectomy with inguinofemoral node dissection is the procedure of choice for stage Ib, II, and III diseases. The high compliance rate with international standards in our study reflects an optimum standard of care provided for the management of these patients at our tertiary care hospital. The audit and subsequent dissemination of results may prove useful in the centralization of care for this rare gynecological cancer.